PCSA - Processa Pharmaceuticals Inc
IEX Last Trade
1.38
-0.010 -0.725%
Share volume: 10,721
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.39
-0.01
-0.72%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-4.83%
1 Month
-39.47%
3 Months
-12.66%
6 Months
-41.53%
1 Year
-80.29%
2 Year
-97.53%
Key data
Stock price
$1.38
DAY RANGE
N/A - $1.39
52 WEEK RANGE
$1.30 - $18.00
52 WEEK CHANGE
-$0.79
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO:
Region: US
Website: processapharma.com
Employees: 14
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: processapharma.com
Employees: 14
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.
Recent news